The tumor suppressor p53, a key regulator of cancer metabolism, activates OVOL2 by binding to the oncoprotein mouse double minute 2 homolog (MDM2) and inhibiting MDM2‐mediated ubiquitination and degradation of OVOL2. The gene discussed is TP53; the disease is cancer.